FDA 510(k) clears MagVenture’s MagVita TMS

by Fink Densford at MassDevice.com

Non-invasive magnetic stimulation developer MagVenture said last month it won FDA 510(k) clearance for its MagVita transcranial magnetic stimulation therapy system.

The device, which uses magnetic fields and electric currents to excite and depolarize neurons in the brain and nervous system, is indicated for treating major depressive disorder in patients non-receptive to antidepressant medication, the company said.

“I am very pleased to hear of the clearance by the FDA of the MagVenture device for the treatment of major depression. The MagVenture device is the latest TMS device to be cleared by the FDA and offers a treatment alternative for psychiatrists who are managing cases of treatment resistant depression. I have personally worked with the MagVenture MagPro device for 7 years now and find its ease of use and reliability very attractive,” Dr. John O’Reardon of Rowan University said in prepared remarks.

See the full article here.

With more than 61,000 510(k) summaries to search, including more than 76,000 splash pages (nearly 138,000 records total), quickly find your primary predicate, multiple predicates or reference devices with kBLASTER. Save time with kBLASTER's effective result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so mobile devices or computers can be used interchangeably to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spending by enabling self-service extraction of actionable insight from FDA medical device 510(k) clearance summaries.